FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1912711617> ?p ?o ?g. }

• W1912711617 endingPage "517" @default.
• W1912711617 startingPage "511" @default.
• W1912711617 abstract "Background Information on certain immunological parameters in patients with pemphigus vulgaris (PV) treated with rituximab (RTX) and intravenous immunoglobulin (IVIG) therapy is limited. Objective Comparing immunological parameters in patients who achieved long-term clinical remission (LTR) with those who relapsed. Methods Retrospective analysis of 19 patients treated at a single centre using the same protocol. Comparisons were made between patients who went into LTR and those who relapsed following completion of the protocol. Treatments prior to IVIG and RTX included prednisone with or without an immunosuppressive agent. The immunological parameters measured included peripheral blood B cells (CD19+), serum quantitative immunoglobulin levels, and levels of antibodies to desmogleins (Dsg) 1 and 3. Results Eleven patients achieved LTR. Eight patients developed 15 relapses. The mean follow-up time for the LTR group was 29·6 ± 11·2 months, and for the relapse group, 40·0 ± 7·0 months. There were no significant differences in times to B-cell depletion, repopulation, or recovery to pretreatment levels between the patients who achieved LTR and those who relapsed. Recurrences usually occurred after B-cell repopulation. Repeated treatments did not influence the time to B-cell repopulation. IgM levels were decreased after therapy and remained decreased. A consistent increase in anti-Dsg1 antibody levels occurred at the time of relapse in patients with mucocutaneous disease. Conclusions The majority of patients treated with rituximab and IVIG therapy achieved LTR. Retreatment of relapses can induce LTR. Decreased serum IgM levels persisted following treatment. Increases in anti-Dsg1 antibodies during therapy in patients with mucocutaneous disease suggests a close follow-up for a potential relapse is required." @default.
• W1912711617 created "2016-06-24" @default.
• W1912711617 creator A5006861944 @default.
• W1912711617 creator A5061811305 @default.
• W1912711617 creator A5089918546 @default.
• W1912711617 date "2012-01-19" @default.
• W1912711617 modified "2023-10-18" @default.
• W1912711617 title "Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy" @default.
• W1912711617 cites W1932566429 @default.
• W1912711617 cites W1963634637 @default.
• W1912711617 cites W1967938091 @default.
• W1912711617 cites W1970540337 @default.
• W1912711617 cites W1973903141 @default.
• W1912711617 cites W1976185035 @default.
• W1912711617 cites W1998618256 @default.
• W1912711617 cites W2006779897 @default.
• W1912711617 cites W2010287671 @default.
• W1912711617 cites W2017431273 @default.
• W1912711617 cites W2031001939 @default.
• W1912711617 cites W2040876247 @default.
• W1912711617 cites W2055031872 @default.
• W1912711617 cites W2059501452 @default.
• W1912711617 cites W2063150581 @default.
• W1912711617 cites W2064790068 @default.
• W1912711617 cites W2077286174 @default.
• W1912711617 cites W2081937747 @default.
• W1912711617 cites W2085142213 @default.
• W1912711617 cites W2089016290 @default.
• W1912711617 cites W2118994799 @default.
• W1912711617 cites W2120741582 @default.
• W1912711617 cites W2122715855 @default.
• W1912711617 cites W2125076165 @default.
• W1912711617 cites W2144047233 @default.
• W1912711617 cites W2154394042 @default.
• W1912711617 cites W2158319513 @default.
• W1912711617 cites W2168877333 @default.
• W1912711617 cites W2169175908 @default.
• W1912711617 cites W2264636885 @default.
• W1912711617 cites W2317276018 @default.
• W1912711617 doi "https://doi.org/10.1111/j.1365-2133.2011.10658.x" @default.
• W1912711617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21967407" @default.
• W1912711617 hasPublicationYear "2012" @default.
• W1912711617 type Work @default.
• W1912711617 sameAs 1912711617 @default.
• W1912711617 citedByCount "26" @default.
• W1912711617 countsByYear W19127116172013 @default.
• W1912711617 countsByYear W19127116172014 @default.
• W1912711617 countsByYear W19127116172015 @default.
• W1912711617 countsByYear W19127116172016 @default.
• W1912711617 countsByYear W19127116172017 @default.
• W1912711617 countsByYear W19127116172018 @default.
• W1912711617 countsByYear W19127116172019 @default.
• W1912711617 countsByYear W19127116172020 @default.
• W1912711617 countsByYear W19127116172021 @default.
• W1912711617 countsByYear W19127116172022 @default.
• W1912711617 countsByYear W19127116172023 @default.
• W1912711617 crossrefType "journal-article" @default.
• W1912711617 hasAuthorship W1912711617A5006861944 @default.
• W1912711617 hasAuthorship W1912711617A5061811305 @default.
• W1912711617 hasAuthorship W1912711617A5089918546 @default.
• W1912711617 hasConcept C126322002 @default.
• W1912711617 hasConcept C156662089 @default.
• W1912711617 hasConcept C159654299 @default.
• W1912711617 hasConcept C197934379 @default.
• W1912711617 hasConcept C203014093 @default.
• W1912711617 hasConcept C2777805810 @default.
• W1912711617 hasConcept C2778375690 @default.
• W1912711617 hasConcept C2778720950 @default.
• W1912711617 hasConcept C2778957590 @default.
• W1912711617 hasConcept C2779134260 @default.
• W1912711617 hasConcept C2780653079 @default.
• W1912711617 hasConcept C2781313415 @default.
• W1912711617 hasConcept C2781327288 @default.
• W1912711617 hasConcept C71924100 @default.
• W1912711617 hasConcept C90924648 @default.
• W1912711617 hasConceptScore W1912711617C126322002 @default.
• W1912711617 hasConceptScore W1912711617C156662089 @default.
• W1912711617 hasConceptScore W1912711617C159654299 @default.
• W1912711617 hasConceptScore W1912711617C197934379 @default.
• W1912711617 hasConceptScore W1912711617C203014093 @default.
• W1912711617 hasConceptScore W1912711617C2777805810 @default.
• W1912711617 hasConceptScore W1912711617C2778375690 @default.
• W1912711617 hasConceptScore W1912711617C2778720950 @default.
• W1912711617 hasConceptScore W1912711617C2778957590 @default.
• W1912711617 hasConceptScore W1912711617C2779134260 @default.
• W1912711617 hasConceptScore W1912711617C2780653079 @default.
• W1912711617 hasConceptScore W1912711617C2781313415 @default.
• W1912711617 hasConceptScore W1912711617C2781327288 @default.
• W1912711617 hasConceptScore W1912711617C71924100 @default.
• W1912711617 hasConceptScore W1912711617C90924648 @default.
• W1912711617 hasIssue "3" @default.
• W1912711617 hasLocation W19127116171 @default.
• W1912711617 hasLocation W19127116172 @default.
• W1912711617 hasOpenAccess W1912711617 @default.
• W1912711617 hasPrimaryLocation W19127116171 @default.
• W1912711617 hasRelatedWork W1912711617 @default.
• W1912711617 hasRelatedWork W1971649560 @default.
• W1912711617 hasRelatedWork W2410078214 @default.

• next